Vaxart, Inc. (VXRT) Form S-1/A — May 15, 2026
Vaxart, Inc. filed Amendment No. 1 to its Form S-1 registration statement to include a $25 million equity line of credit agreement with Lincoln Park. This facility allows Vaxart to sell shares to Lincoln Park at a 3% discount to the market price, with a floor price of $0.10 per share.
Key figures
- Deal Value Usd
- 25000000
- Gross Proceeds
- 25000000
- Offering Price
- 97% of market price (discounted)
- Shares Offered
- Up to 4.99% of outstanding shares (variable)
- Floor Price
- 0.1
- Commitment Shares
- 447067
- Regular Purchase Limit
- 150000
- Beneficial Ownership Limit
- 4.99%
- Accelerated Purchase Discount
- 3%
Price after filing
1 day: 0.0%7 days: -5.9%30 days: -17.6%
Close on the filing date to close N calendar days later (from $0.68). Historical, not a forecast.
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.